Shilpa B. Raval, M.D.
NPI 1154362929ActiveIndividual· Internal Medicine· Warsaw, IN
Internal Medicine (M.D.) in Warsaw, Indiana, licensed in IN, with an NPI issued in June 2006. Part D covered 84 prescriptions written in 2024, 96% of them generic. Novo Nordisk Inc was the largest of 3 companies reporting payments in 2025, $594.24 in all, mostly food and beverage.
Overview
| NPI | 1154362929 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jun 10, 2006 |
| Last updated in NPPES | May 27, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine Primary | 207R00000X | 01061146A | IN |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 84 · 232 30-day fills |
|---|---|
| Patients | 15 |
| Total drug cost | $1,379 |
| Generic share | 96% of claims |
Industry payments (Open Payments)
- 2025$594.24 · 29 payments from 3 companies
- 2024$431.96 · 10 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $419.37 | 13 |
| Amgen Inc. | $159.85 | 15 |
| Lilly USA, LLC | $15.02 | 1 |
What the 2025 payments were for
- Food and Beverage$594.24 · 29 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine providers in Warsaw
- 1407960206
- 1598798589
- 1447216213
- 1851357032
- 1578529020
- 1023755519
- 1639135155